Bartik, M M <br/><br/>
Enhanced expansion of the thymic CD8+ cell subset as a potential mechanism for the generation of enhanced antitumor cytotoxicity by thymocytes from low-dose melphalan-treated MOPC-315 tumor bearers.  [electronic resource] 

 -  Cancer immunology, immunotherapy : CII  1991 
 - 79-89 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0340-7004 
<br/><br/><label>Standard No.: </label>10.1007/BF01741340  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>CD4-CD8 Ratio<br/>CD8 Antigens--analysis<br/>Cytotoxicity, Immunologic--drug effects<br/>Female<br/>Interleukin-2--pharmacology<br/>Lymphocyte Activation<br/>Melphalan--administration & dosage<br/>Mice<br/>Mice, Inbred BALB C<br/>Plasmacytoma--drug therapy<br/>Recombinant Proteins--pharmacology<br/>T-Lymphocyte Subsets--drug effects<br/>Thymoma--immunology